CAPRICOR THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Capricor Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Capricor Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 7, 2024 was 32.5M shares, a 26.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 32.5M +6.76M +26.2% Aug 7, 2024 10-Q 2024-08-08
Q1 2024 31.4M +6.14M +24.3% Mar 7, 2024 10-K 2024-03-11
Q3 2023 30.8M +5.55M +22% Nov 13, 2023 10-Q 2023-11-14
Q2 2023 25.8M +1.43M +5.88% Aug 7, 2023 10-Q 2023-08-08
Q1 2023 25.3M +957K +3.94% Mar 16, 2023 10-K 2023-03-17
Q3 2022 25.2M +1.09M +4.52% Nov 9, 2022 10-Q 2022-11-10
Q2 2022 24.3M +1.32M +5.75% Aug 10, 2022 10-Q 2022-08-12
Q1 2022 24.3M +1.5M +6.58% Mar 9, 2022 10-K 2022-03-11
Q3 2021 24.1M +3.7M +18.1% Nov 9, 2021 10-Q 2021-11-12
Q2 2021 23M +3.3M +16.7% Aug 12, 2021 10-Q 2021-08-13
Q1 2021 22.8M +13.9M +156% Mar 12, 2021 10-K 2021-03-15
Q3 2020 20.4M +16.2M +382% Nov 12, 2020 10-Q 2020-11-13
Q2 2020 19.7M +16M +428% Aug 7, 2020 10-Q 2020-08-10
Q1 2020 8.91M -24.8M -73.5% Mar 27, 2020 10-K 2020-03-27
Q3 2019 4.25M -26.8M -86.3% Nov 8, 2019 10-Q 2019-11-08
Q2 2019 3.74M -27M -87.9% Aug 7, 2019 10-Q 2019-08-08
Q1 2019 33.7M +5.95M +21.5% Mar 28, 2019 10-K 2019-03-29
Q3 2018 31.1M +5.36M +20.8% Nov 14, 2018 10-Q 2018-11-14
Q2 2018 30.7M +7.25M +30.9% Aug 9, 2018 10-Q 2018-08-13
Q1 2018 27.7M +6.31M +29.5% Mar 20, 2018 10-K 2018-03-22
Q3 2017 25.7M +4.31M +20.1% Nov 10, 2017 10-Q 2017-11-14
Q2 2017 23.5M +5.54M +30.9% Aug 10, 2017 10-Q 2017-08-14
Q1 2017 21.4M +3.45M +19.2% Mar 14, 2017 10-K 2017-03-16
Q3 2016 21.4M +5.14M +31.6% Nov 11, 2016 10-Q 2016-11-14
Q2 2016 18M +1.7M +10.5% Aug 12, 2016 10-Q 2016-08-15
Q1 2016 18M +1.73M +10.7% Mar 29, 2016 10-K 2016-03-30
Q3 2015 16.3M +4.55M +38.9% Nov 12, 2015 10-Q 2015-11-13
Q2 2015 16.3M +4.55M +38.9% Aug 12, 2015 10-Q 2015-08-14
Q1 2015 16.2M +4.53M +38.8% Mar 13, 2015 10-K 2015-03-16
Q3 2014 11.7M -31.8M -73.1% Nov 12, 2014 10-Q 2014-11-14
Q2 2014 11.7M -31.4M -72.8% Aug 12, 2014 10-Q 2014-08-14
Q1 2014 11.7M Mar 26, 2014 10-K 2014-03-31
Q3 2013 43.5M Nov 12, 2013 10-Q 2013-11-14
Q2 2013 43.1M 0 0% Jun 19, 2013 10-Q 2013-06-21
Q2 2012 43.1M +3.35M +8.45% Aug 13, 2012 10-Q/A 2012-09-10
Q1 2012 39.7M Mar 29, 2012 10-K 2012-04-02
Q3 2011 39.7M Nov 11, 2011 10-Q 2011-11-14
Q2 2011 39.7M Aug 12, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.